Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Finished Goods (2018 - 2025)

Historic Finished Goods for Immucell (ICCC) over the last 8 years, with Q3 2025 value amounting to $2.0 million.

  • Immucell's Finished Goods rose 876885.88% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 876885.88%. This contributed to the annual value of $9530.0 for FY2024, which is 9763.3% down from last year.
  • Per Immucell's latest filing, its Finished Goods stood at $2.0 million for Q3 2025, which was up 876885.88% from $1.2 million recorded in Q2 2025.
  • Immucell's 5-year Finished Goods high stood at $2.0 million for Q3 2025, and its period low was $9530.0 during Q4 2024.
  • Over the past 5 years, Immucell's median Finished Goods value was $385811.0 (recorded in 2023), while the average stood at $460858.2.
  • In the last 5 years, Immucell's Finished Goods crashed by 9763.3% in 2024 and then surged by 876885.88% in 2025.
  • Over the past 5 years, Immucell's Finished Goods (Quarter) stood at $29381.0 in 2021, then surged by 410.04% to $149855.0 in 2022, then skyrocketed by 168.67% to $402619.0 in 2023, then crashed by 97.63% to $9530.0 in 2024, then skyrocketed by 20645.5% to $2.0 million in 2025.
  • Its Finished Goods stands at $2.0 million for Q3 2025, versus $1.2 million for Q2 2025 and $40747.0 for Q1 2025.